Cell Line Data
Clinical samples
Breast cancer
Ovarian cancer
Glioblastoma
Colorectal carcinoma
Immunotherapy
Custom data
Downloads
Contact
Immunotherapy
Home
Immunotherapy
Plotter
Results
Plotter
1. Gene symbol
2. Response
Combined response (n=1,434)
3. Treatment
Anti PD-1 (CD279) therapy
any anti PD-1
nivolumab
pembrolizumab
Anti PD-L1 (CD274) therapy
any anti PD-L1
atezolizumab
durvalumab
Anti CTLA4 (CD152) therapy
any anti CTLA-4
ipilimumab
Any
any immune checkpoint inhibitor therapy
Total:
0
Non-responders:
0
Responders:
0
4. Filters (optional)
Sample acquisition
All
Pretreatment(n = 1267)
Ontreatment (n = 167)
Gender
All
Male (n = 801)
Female (n = 350)
Primary tumor
All
No (n = 164)
Yes (n = 552)
Metastatic
All
No (n = 120)
Yes (n = 988)
5. Settings
Tissue of origin
Non Small Cell Lung Cancer
Glioblastoma
Ureter/ Renal Pelvis
Gastric Cancer
Colorectal
Urothelial
Melanoma
Bladder
Hepatocellular Carcinoma
Non Squamous Lung Cancer
Small Cell Lung Cancer
Esophageal Adeno
Breast
Renal Cell Carcinoma
Squamous Lung Cancer
Head And Neck Squamous Cell Carcinoma
All
No outliers
Show quartiles
Signature
Results
Please run the analysis first